NCT02859688

Brief Summary

Like genetic mutations, DNA methylation anomalies or epimutations can disrupt gene expression and lead to human diseases. However, unlike genetic mutations, epimutations can in theory be reverted through developmental epigenetic re-programing, which should limit their transmission across generations. Following the request for a parental project of a patient diagnosed with Silver-Russell syndrome (SRS), and the availability of both somatic and spermatozoa DNA from the proband and his father, we had the exceptional opportunity to evaluate the question of inheritance of an epimutation. We provide here for the first time evidence for efficient reversion of a constitutive epimutation in the spermatozoa of an SRS patient, which has important implication for genetic counseling.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 2, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 9, 2016

Completed
Last Updated

August 9, 2016

Status Verified

July 1, 2016

Enrollment Period

2 months

First QC Date

August 2, 2016

Last Update Submit

August 4, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Analysis of levels of methylation of deoxyribonucleic acid (DNA) measured by cloning/ sequencing and/or pyrosequencing for genes susceptible to imprinting (GSI)

    Through the study completion up to 1 month

Study Arms (3)

SRS patient

Genetic: pyrosequencingGenetic: Methylome

father SRS patient

Genetic: pyrosequencingGenetic: Methylome

control patient

Genetic: pyrosequencingGenetic: Methylome

Interventions

SRS patientcontrol patientfather SRS patient
MethylomeGENETIC
SRS patientcontrol patientfather SRS patient

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1 patient SRS, the father of the patient SRS and 5 control patients : healthy men, age-matched

You may qualify if:

  • Men who have been informed about the study
  • Patients over 18 years old
  • Fertile
  • Matched for age with Silver Russel syndrome (SRS) patients

You may not qualify if:

  • Adults under guardianship
  • Patients without national health insurance cover
  • Patients with psychomotor development diseases or pulmonary, cardiac, renal or metabolic diseases (including type 1 and 2 diabetes before the pregnancy), inflammatory and systemic diseases, hypertension, neurological diseases, chronic hepatitis B or C, infection with human immunodeficiency virus (HIV).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Dijon Bourgogne

Dijon, 21079, France

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood, sperm, saliva, skin biopsy

MeSH Terms

Interventions

High-Throughput Nucleotide SequencingEpigenome

Intervention Hierarchy (Ancestors)

Sequence AnalysisGenetic TechniquesInvestigative TechniquesGenomeGenetic StructuresGenetic Phenomena

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2016

First Posted

August 9, 2016

Study Start

May 1, 2015

Primary Completion

July 1, 2015

Last Updated

August 9, 2016

Record last verified: 2016-07

Locations